Integrating Multiomics Analysis in Cancer and Rare Disease Research

Integrating Multiomics Analysis in Cancer and Rare Disease Research Long-read whole genome sequencing produces a comprehensive catalog of genomic variants, enabling deep profiling of the genome’s most complex regions. However, interpreting genetic variants remains a significant bottleneck. For patients with cancer or rare disease, being able to unlock genetic insights at speed is critical. In this webinar, our expert speakers will discuss how a new multiomics platform can establish associations between phenotypes and genomic variants and deliver insights into small variants, structural variants and short tandem repeats. Our speakers will outline how automating the interpretation of this clinical data can alleviate analysis bottlenecks, enabling faster decision-making and diagnosis for cancer and rare disease. Discover the multiomics approaches transforming oncology and rare disease research Hear how whole-genome data analysis enables rapid and accurate clinical decision-making Learn how Oxford Nanopore technology can facilitate the discovery of genetic variations in previously inaccessible genome regions Mohammed Uddin, PhD Neurogeneticist and Founder Jawahar Swaminathan, PhD Director of Informatics, Clinical Solutions